• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Enhertu

Stylized 3D rendering of a DNA double helix structure set against a purple and pink background with molecular particles floa
Podcast

Inside ASCO 2025: Big data drops and a towering campaign

In this episode of "The Top Line," the Fierce team reports from ASCO with takeaways on clinical data, standout campaigns and exhibit floor buzz.
Ayla Ellison , Angus Liu , Gabrielle Masson , Zoey Becker Jun 6, 2025 10:39am
Asia

PD-1 bispecifics, Enhertu, Regeneron-Hansoh—Fierce Pharma Asia

Jun 6, 2025 7:15am
Enhertu

ASCO: AZ, Daiichi flex Enhertu muscle in 2 cancers

Jun 2, 2025 8:00am
ranking gold star leader

AZ, Merck duke it out to lead oncologists’ pharma perceptions

May 22, 2025 10:54am
sustainability green goals

Pfizer partner touts HER2 ADC trial win in bladder cancer

May 12, 2025 10:59am
Asia

Enhertu, Takeda, Trump—Fierce Pharma Asia

May 9, 2025 6:15am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings